Skip to main content

Q - Ceribell,

For the period ended Jun 30, 2025. Filed Aug 5, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 5, 2025

CBLL$27.48-0.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Statements of Operations and Comprehensive Loss

(in thousands, except share and per share data)

Three months ended June 30,Six months ended June 30,
2025202420252024
Revenue
Product revenue$15,923$11,576$31,531$22,611
Subscription revenue5,2763,73910,1597,104
Total revenue21,19915,31541,69029,715
Cost of revenue
Product cost of goods sold2,3512,0334,7113,977
Subscription cost of revenue166123290237
Total cost of revenue2,5172,1565,0014,214
Gross profit18,68213,15936,68925,501
Operating expenses
Research and development4,8523,2709,0986,254
Sales and marketing17,42210,71235,45521,288
General and administrative11,3607,61221,29514,847
Total operating expenses33,63421,59465,84842,389
Loss from operations(14,952)(8,435)(29,159)(16,888)
Interest expense(477)(528)(948)(963)
Change in fair value of warrant liability—(242)—(244)
Other income, net1,7862643,687633
Loss, before provision for income taxes(13,643)(8,941)(26,420)(17,462)
Provision for income tax expense————
Net loss$(13,643)$(8,941)$(26,420)$(17,462)
Net loss per share attributable to common stockholders:
Basic and diluted(0.38)(1.61)(0.73)(3.17)
Weighted-average shares used in computing net loss per share attributable to common stockholders:
Basic and diluted36,293,5595,559,71836,088,4335,506,597
Other comprehensive loss
Unrealized gain on marketable securities$11$—$5$—
Comprehensive loss$(13,632)$(8,941)$(26,415)$(17,462)
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.